Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma

NCT01739244 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Ocular Hypertension
Open Angle Glaucoma

Interventions

DRUG: SYL040012
DRUG: Placebo

Sponsor

Sylentis, S.A.